[13C6]-Prasugrel metabolite derivative hydrochloride (mixture of diastereomers)

[13C6]-Prasugrel metabolite derivative hydrochloride (mixture of diastereomers) is a chemical compound that is used in the pharmaceutical industry. It is a derivative of Prasugrel, which is an antiplatelet medication used to prevent blood clots in people with acute coronary syndrome undergoing percutaneous coronary intervention. The [13C6]-Prasugrel metabolite derivative hydrochloride (mixture of diastereomers) is a stable isotopic labeled analog of one of the major metabolites of Prasugrel, which allows for the tracking and quantification of Prasugrel and its metabolites in vivo. Chemically, the compound is a mixture of diastereomers, which means that it contains two or more stereoisomers that are not mirror images of each other. The compound is made up of Prasugrel and a hydrochloride salt, as well as six carbon-13 isotopes, which are stable and non-radioactive isotopes of carbon. This makes the compound useful for tracing the metabolic fate of Prasugrel in vivo, as the isotopic label can be detected using various analytical techniques, such as mass spectrometry. In terms of usage, [13C6]-Prasugrel metabolite derivative hydrochloride (mixture of diastereomers) is primarily used in preclinical and clinical studies to investigate the pharmacokinetics and metabolism of Prasugrel in humans and animals. Its stable isotopic label allows for precise quantification of Prasugrel and its metabolites in biological samples, which can provide valuable insights into the drug's efficacy and safety. Overall, [13C6]-Prasugrel metabolite derivative hydrochloride (mixture of diastereomers) is a powerful tool in drug development and pharmacological research.